Clinicopathological Features of Tumors as Predictors of the Efficacy of Primary Neoadjuvant Chemotherapy for Operable Breast Cancer-Reference-Cited by-同舟云学术

Clinicopathological Features of Tumors as Predictors of the Efficacy of Primary Neoadjuvant Chemotherapy for Operable Breast Cancer

Published:2008-10-25 Issue:1 Volume:33 Page:44-51
ISSN:0364-2313
Container-title:World Journal of Surgery
language:en
Short-container-title:World J Surg

Author:

Shien Tadahiko,Akashi-Tanaka Sadako,Miyakawa Kunihisa,Hojo Takashi,Shimizu Chikako,Seki Kunihiko,Ando Masashi,Kohno Tsutomu,Taira Naruto,Doihara Hiroyoshi,Katsumata Noriyuki,Fujiwara Yasuhiro,Kinoshita Takayuki

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00268-008-9800-9.pdf

Reference22 articles.

1. Bear HD, Anderson S, Smith RE et al (2006) Sequential preoperatrive or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 24:1–9

2. Buzdar AU, Ibrahim NK, Francis D, Booser DJ, Thomas ES, Theriault RL, Pusztai L, Green MC, Arun BK, Giordano SH, Cristofanilli M, Frye DK, Smith TL, Hunt KK, Singletary SE, Sahin AA, Ewer MS, Buchholz TA, Berry D, Hortobagyi GN (2005) Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol 23:3676–3685

3. Hayes DF, Thor AD, Dressler LG, Weaver D, Edgerton S, Cowan D, Broadwater G, Goldstein LJ, Martino S, Ingle JN, Henderson IC, Norton L, Winer EP, Hudis CA, Ellis MJ, Berry DA (2007) HER2 and response to paclitaxel in node-positive breast cancer. N Engl J Med 357:1496–1506

4. Japanese Breast Cancer Society (2005) General rules for clinical and pathological recording of breast cancer. Breast Cancer 12:S12–S14

5. (1981) Histological Typing of Breast Tumours. International Histological Classification of Tumours. No. 2. World Health Organization, Geneva, pp 18–22

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Tumor Elasticity and Clinicopathologic Factors Affecting Neoadjuvant Chemotherapy Response in Patients with Breast Cancer;Journal of Breast Disease;2021-06-28

2. Machine Learning Frameworks to Predict Neoadjuvant Chemotherapy Response in Breast Cancer Using Clinical and Pathological Features;JCO Clinical Cancer Informatics;2021-01

3. Combination of survivin siRNA with neoadjuvant chemotherapy enhances apoptosis and reverses drug resistance in breast cancer MCF-7 cells;Journal of Cancer Research and Therapeutics;2015

4. The detection of pCR after PST by contrast-enhanced ultrasonography for breast cancer;Breast Cancer;2011-12-28

5. Clinical and Pathological Features of Breast Cancer Associated with the Pathological Complete Response to Anthracycline-Based Neoadjuvant Chemotherapy;Oncology;2011